Citigroup lifted its price objective on Moderna, while CLSA raised Moderna to an outperform rating.

The entities involved

• Moderna →

  American biotechnology company

  • Moderna and Arcturus Therapeutics are being compared for investment as healthcare companies.Thu 05:06
  • Arbutus Biopharma filed patent enforcement lawsuits against Pfizer and sued Moderna regarding LNP patent infringement.Tue 15:13
• Citigroup →

  American investment bank and financial services corporation

  • Citigroup lifted its price target on Federal Realty Investment Trust (FRT), and Scotiabank boosted its price objective for the company.Thu 11:37
  • Morgan Stanley and Citigroup cut AutoNation's rating and price objective on November 6, 2026.Thu 11:20
• CLSA →

  Capital markets and investment group

  • CLSA maintained a positive outlook on Hindustan Aeronautics Limited (HAL), a state-run aerospace and defence major.Thu 13:21
  • CLSA reiterated an outperform rating on AMD stock on November 11, 2026.Wed 13:32

Related events

• Citigroup adjusted its price target for Winnebago Industries on June 26, 2025.Jun 8
• Citigroup lifted its price objective on Newmont Corporation stock.Nov 4
• Citigroup maintained a market outperform rating for Ethos Technologies Inc. on November 6, 2026.Nov 6
• Citigroup reiterated a market outperform rating for Capital Southwest Corporation.Oct 31
• Citigroup reiterated an outperform rating for Alta Equipment Group on November 9, 2026.Mon 23:42